Company · Ownership research

Tarsus Pharmaceuticals, Inc. TARS

CIK 0001819790

Form 4 transactions dated Nov 1, 2023 to Nov 10, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 74 rows; the complete set is available through the API.

Insider filings on file run through Nov 5, 2026.

Insider purchases & sales

Purchased: $18.96K
Sold: $30.31M

Nov 1, 2023 – Nov 5, 2026
Available records · partial months are marked ·

202510 of 30 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
Dec 24, 2025	Azamian Bobak R. President/CEO and Board Chair · Director	Sale10b5-1 footnote	$495.09K 6,000 shares sold	0.69% sold Trust holding	▾
Dec 16, 2025	Whitfield Dianne C. Chief Human Resources Officer	Sale10b5-1 footnote	$592.50K 7,397 shares sold	15.96% sold Direct holding	▾
Dec 16, 2025	Lin Elizabeth Yeu Chief Medical Officer	Sale	$165.20K 2,078 shares sold	8.65% sold Direct holding	▾
Dec 15, 2025	LINK WILLIAM J PHD Director	Sale10b5-1 footnote	$1.02M 12,500 shares sold	8.84% sold Direct holding	▾
Dec 15, 2025	LINK WILLIAM J PHD Director	Sale10b5-1 footnote	$846.86K 10,446 shares sold	100.00% sold Indirect holding	▾
Sep 24, 2025	Azamian Bobak R. President/CEO and Board Chair · Director	Sale10b5-1 footnote	$332.22K 6,000 shares sold	0.73% sold Trust holding	▾
Sep 8, 2025	LINK WILLIAM J PHD Director	Sale	$1.55M 27,116 shares sold	15.91% sold Direct holding	▾
Aug 11, 2025	Azamian Bobak R. President/CEO and Board Chair · Director	Sale10b5-1 footnote	$300.00K 6,000 shares sold	0.73% sold Trust holding	▾
Jun 17, 2025	Farrow Jeffrey S See Remarks	Sale	$550.04K 13,608 shares sold	27.05% sold Direct holding	▾
Jun 16, 2025	Lin Elizabeth Yeu Chief Medical Officer	Sale	$41.33K 1,006 shares sold	11.56% sold Direct holding	▾

Showing 30 / 30 record groups in 2025. The complete set is available through the API.

Tarsus Pharmaceuticals, Inc. · TARS

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 30 of 30 purchase / sale groups and 30 of 74 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"TARS","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.